Long-term safety and efficacy of adalimumab in psoriasis: a multicentric study focused on infections (connecting study).

Conclusions: Adalimumab is effective and safe in patients affected by these important infections. PMID: 32792888 [PubMed]
Source: Advances in Dermatology and Allergology - Category: Dermatology Tags: Postepy Dermatol Alergol Source Type: research